CASI Pharmaceuticals
CASI • NASDAQ
CASI Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO David A. Cory, with a market cap of $19.5M.
CEODavid A. Cory
Next Earnings
Upcoming earnings announcement for CASI Pharmaceuticals
Date
Monday, March 30, 2026 (in 2 months)
Timing
Before Market Open (8:00 AM New York)
Fiscal Period
Q4 2025
EPS Estimate
-$0.36
Earnings History
Past 12 earnings reports for CASI Pharmaceuticals
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 14, 2025 | Q3 2025 | -$0.67Est: -$0.40 | -67.5% | $3.1M | — | — |
| Aug 29, 2025 | Q2 2025 | -$0.86Est: -$0.47 | -83.0% | $4.2MEst: $6.3M | -33.5% | — |
| May 16, 2025 | Q1 2025 | -$0.69Est: -$0.60 | -15.0% | $6.2MEst: $6.1M | +2.3% | — |
| Mar 31, 2025 | Q4 2024 | -$0.79Est: $0.00 | — | $13.4MEst: $7.4M | +80.7% | — |
| Nov 15, 2024 | Q3 2024 | -$0.55Est: -$0.62 | +11.3% | $7.8MEst: $4.6M | +70.9% | — |
| Aug 16, 2024 | Q2 2024 | -$0.52Est: -$0.63 | +17.5% | $4.0MEst: $4.4M | -10.2% | — |
| May 14, 2024 | Q1 2024 | -$0.71Est: -$0.05 | -1320.0% | $3.4MEst: $12.0M | -71.6% | — |
| Mar 28, 2024 | Q4 2023 | -$0.45Est: -$0.24 | -87.5% | $6.9MEst: $9.4M | -27.0% | — |
| Nov 14, 2023 | Q3 2023 | -$0.35Est: -$0.56 | +37.5% | $8.8MEst: $10.4M | -15.0% | — |
| Aug 11, 2023 | Q2 2023 | -$0.77Est: -$0.50 | -54.0% | $9.8MEst: $10.1M | -2.7% | — |
| May 17, 2023 | Q1 2023 | -$0.45Est: -$0.64 | +29.7% | $8.3MEst: $9.1M | -8.3% | — |
| Apr 26, 2023 | Q4 2022 | -$1.44Est: -$0.37 | -289.2% | $15.3MEst: $10.8M | +41.4% | — |